- Source: DTaP-IPV/Hib vaccine
DTaP-IPV/Hib vaccine is a 5-in-1 combination vaccine that protects against diphtheria, tetanus, whooping cough, polio, and Haemophilus influenzae type B.
Its generic name is "diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate vaccine", and it is also known as DTaP-IPV-Hib.
Uses
DTaP-IPV/Hib vaccine is administered to young children to immunise against diphtheria, tetanus, pertussis, poliomyelitis, and diseases caused by Haemophilus influenzae type B.
Formulations
A branded formulation marketed in the United States is Pentacel, manufactured by Sanofi Pasteur.
Pentacel is known in the UK and Canada as Pediacel.
An equivalent vaccine marketed in the UK and Canada by GlaxoSmithKline is Infanrix IPV + Hib. This is a two-part vaccine. The DTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried) Hib vaccine.
Pentaxim is a liquid formulation marketed by Sanofi Pasteur.
Availability
It is only licensed for young children. The United States Food and Drug Administration has approved the vaccine for children from age 6 weeks up to age 5 years. It was used in the UK until 2017, following which a 6-in-1 vaccine became available containing the additional protection against Hepatitis B.
References
Kata Kunci Pencarian:
- DTaP-IPV/Hib vaccine
- Hib vaccine
- DTaP-IPV vaccine
- DTwP-HepB-Hib vaccine
- DTaP-IPV-HepB vaccine
- DPT vaccine
- Hexavalent vaccine
- DTaP-Hib vaccine
- DPT-Hib vaccine
- Pentavalent vaccine
